Literature DB >> 17108026

Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.

Vladimir Majerciak1, Natalia Pripuzova, J Philip McCoy, Shou-Jiang Gao, Zhi-Ming Zheng.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 regulates viral gene expression at the posttranscriptional level during viral lytic infection. To study its function in the context of the viral genome, we disrupted KSHV ORF57 in the KSHV genome by transposon-based mutagenesis. The insertion of the transposon into the ORF57 exon 2 region also interrupted the 3' untranslated region of KSHV ORF56, which overlaps with the ORF57 coding region. The disrupted viral genome, Bac36-Delta57, did not express ORF57, ORF59, K8alpha, K8.1, or a higher level of polyadenylated nuclear RNA after butyrate induction and could not be induced to produce infectious viruses in the presence of valproic acid, a histone deacetylase inhibitor and a novel KSHV lytic cycle inducer. The ectopic expression of ORF57 partially complemented the replication deficiency of the disrupted KSHV genome and the expression of the lytic gene ORF59. The induced production of infectious virus particles from the disrupted KSHV genome was also substantially restored by the simultaneous expression of both ORF57 and ORF56; complementation by ORF57 alone only partially restored the production of virus, and expression of ORF56 alone showed no effect. Altogether, our data indicate that in the context of the viral genome, KSHV ORF57 is essential for ORF59, K8alpha, and K8.1 expression and infectious virus production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108026      PMCID: PMC1797518          DOI: 10.1128/JVI.01558-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells.

Authors:  R N Shaw; J L Arbiser; M K Offermann
Journal:  AIDS       Date:  2000-05-05       Impact factor: 4.177

2.  Herpes simplex virus ICP27 protein provides viral mRNAs with access to the cellular mRNA export pathway.

Authors:  M D Koffa; J B Clements; E Izaurralde; S Wadd; S A Wilson; I W Mattaj; S Kuersten
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.

Authors:  D M Lukac; L Garibyan; J R Kirshner; D Palmeri; D Ganem
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.

Authors:  F Y Wu; J H Ahn; D J Alcendor; W J Jang; J Xiao; S D Hayward; G S Hayward
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

Authors:  M E Ballestas; K M Kaye
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.

Authors:  M Göttlicher; S Minucci; P Zhu; O H Krämer; A Schimpf; S Giavara; J P Sleeman; F Lo Coco; C Nervi; P G Pelicci; T Heinzel
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

8.  Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus.

Authors:  H J Delecluse; M Kost; R Feederle; L Wilson; W Hammerschmidt
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  Characterization of human herpesvirus 8 ORF59 protein (PF-8) and mapping of the processivity and viral DNA polymerase-interacting domains.

Authors:  S R Chan; B Chandran
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin.

Authors:  Cui Li Lin; Hong Li; Yan Wang; Fan Xiu Zhu; Sagar Kudchodkar; Yan Yuan
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  59 in total

1.  Viral factors reveal a role for REF/Aly in nuclear RNA stability.

Authors:  Sarah H Stubbs; Olga V Hunter; Ashley Hoover; Nicholas K Conrad
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

2.  Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.

Authors:  Taeko Kato-Noah; Yiyang Xu; Cyprian C Rossetto; Kelly Colletti; Iva Papousková; Gregory S Pari
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

4.  The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Authors:  Jonathan Guito; Aileen Gavina; Diana Palmeri; David M Lukac
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.

Authors:  Emi Sei; Nicholas K Conrad
Journal:  Virology       Date:  2011-09-01       Impact factor: 3.616

6.  Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL.

Authors:  Diana Palmeri; Kyla Driscoll Carroll; Olga Gonzalez-Lopez; David M Lukac
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

7.  KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182.

Authors:  Nishi R Sharma; Vladimir Majerciak; Michael J Kruhlak; Lulu Yu; Jeong Gu Kang; Acong Yang; Shuo Gu; Marvin J Fritzler; Zhi-Ming Zheng
Journal:  Nucleic Acids Res       Date:  2019-09-26       Impact factor: 16.971

8.  Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.

Authors:  Vladimir Majerciak; Natalia Pripuzova; Calvin Chan; Nicholas Temkin; Suzanne I Specht; Zhi-Ming Zheng
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

10.  Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA.

Authors:  Maria J Massimelli; Vladimir Majerciak; Michael Kruhlak; Zhi-Ming Zheng
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.